Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study

Diabetologia

Volumn 58, Issue 12, 2015, Pages 2774-2780

  Andersson, Charlotte ^a,b   Lyass, Asya ^a,c   Larson, Martin G ^a,c,d   Robins, Sander J ^a   Vasan, Ramachandran S ^a,d,e  

^a FRAMINGHAM HEART STUDY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Boston University   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes risk; Low density lipoprotein concentrations; Mendelian randomisation; Untreated individuals

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENETIC ANALYSIS; GENETIC RISK SCORE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK FACTORS; TRIGLYCERIDES;

EID: 84946491499     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3762-x     Document Type: Article

References (25)

1. Sattar N, Preiss D, Murray HM et al (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375:735–742
2. Landray MJ, Haynes R, Hopewell JC et al (2014) Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 371:203–212
3. Swerdlow DI, Preiss D, Kuchenbaecker KB et al (2015) HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 385:351–361
4. Li N, van der Sijde MR, Bakker SJ et al (2014) Pleiotropic effects of lipid genes on plasma glucose, HbA1c, and HOMA-IR levels. Diabetes 63:3149–3158
5. Fall T, Xie W, Poon W et al (2015) Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes. Diabetes 64:2676–2684
6. Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK (2015) Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313:1029–1036
7. Pihlajamaki J, Gylling H, Miettinen TA, Laakso M (2004) Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 45:507–512
8. Hoenig MR, Sellke FW (2010) Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy. Atherosclerosis 211:260–265
9. Simonen PP, Gylling HK, Miettinen TA (2002) Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25:1511–1515
10. Tsao CW, Preis SR, Peloso GM et al (2012) Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study. J Am Coll Cardiol 60:2364–2371
11. Demant MN, Gislason GH, Kober L, Vaag A, Torp-Pedersen C, Andersson C (2014) Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study. Diabetologia 57:1595–1600
12. Andersson C, Norgaard ML, Hansen PR et al (2010) Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail 12:1333–1338
13. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL (2006) Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48:219–224
14. Niklason A, Hedner T, Niskanen L, Lanke J (2004) Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens 22:645–652
15. Shen L, Shah BR, Reyes EM et al (2013) Role of diuretics, beta blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study. BMJ 347:f6745
16. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
17. Teslovich TM, Musunuru K, Smith AV et al (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466:707–713
18. Cupples LA, DʼAgostino RB, Anderson K, Kannel WB (1988) Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 7:205–222
19. DʼAgostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB (1990) Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 9:1501–1515
20. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, DʼAgostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074
21. Burgess S (2014) Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol 43:922–929
22. Deloukas P, Kanoni S, Willenborg C et al (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
23. Pulai JI, Latour MA, Kwok PY, Schonfeld G (1998) Diabetes mellitus in a new kindred with familial hypobetalipoproteinemia and an apolipoprotein B truncation (apoB-55). Atherosclerosis 136:289–295
24. Jia L, Betters JL, Yu L (2011) Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 73:239–259
25. Preiss D, Sattar N (2015) Does the LDL receptor play a role in the risk of developing type 2 diabetes? JAMA 313:1016–1017